Oxygen–hemoglobin dissociation curve the fluid that surrounds it. Hemoglobin (Hb) is the primary vehicle for transporting oxygen in the blood. Oxygen is also carried dissolved in the blood's plasma, but to a much lesser degree. Hemoglobin is contained in red blood cells. Under certain conditions, oxygen bound to the hemoglobin is released into the blood's plasma and absorbed into the tissues. Each hemoglobin molecule has the capacity to carry four oxygen molecules. These molecules of oxygen bind to the iron of the Heme group. The binding of the first oxygen molecule induces a conformational change of hemoglobin that increases the affinity for the
Genetically engineered blood protein and a substance of choice, such as a small-molecule therapeutic agent or an antibody. The modifications leave the cells and their surfaces otherwise intact. One application is to engineer red blood cells into drug-delivery vehicles. Mature red cells carry no genetic material, potentially presenting fewer safety risks than other gene and cell therapies. Human red blood cells circulate for as long as four months, meaning they could potentially form the basis of long-term therapies. The cells move throughout body via the bloodstream and are unnoticed by the immune system. Genetically engineered blood Genetically engineered blood is blood that has